Aventis SA acquires a minority stake in Genta Inc


US - Aventis SA acquired a #.##% stake, or #.### mil common shares, in Genta Inc, a manufacturer of pharmaceutical products, for $##.## in cash per share, or a total value of $##.### mil, in a privately …

Deal Information

Credit & Investment Research

Market Research

News

Aventis SA Mergers & Acquisitions
Sanofi-Aventis SA acquires remaining interest in Hoechst AG from Aventis SA (7/12/2005 12:00:00 AM)
Sanofi-Synthelabo SA launches a tender offer for Aventis SA from Sanofi-Aventis SA (8/20/2004 12:00:00 AM)
Novartis AG withdraws offer for Aventis SA (4/22/2004 12:00:00 AM)
Aventis SA buys back stock (pending) (4/14/2004 12:00:00 AM)
Rumor dispelled that Procter & Gamble Co was planning acquisition of Aventis SA (1/14/2004 12:00:00 AM)
Wacker Chemie AG acquires remaining interest in Wacker NSCE Corp from Aventis SA (pending) (5/28/2003 12:00:00 AM)
Kuwait Petroleum Corp acquires a minority stake in Aventis SA from Sanofi-Aventis SA (4/9/2003 12:00:00 AM)
Gruppo Mossi & Ghisolfi acquires Rhodia-Ster SA from Aventis SA (10/7/2002 12:00:00 AM)
Investor Group acquires Kermel(Rhone-Poulenc SA) from Aventis SA through a leveraged buyout (8/30/2002 12:00:00 AM)
Bayer AG acquires Aventis CropScience Hldg SA from Aventis SA (6/3/2002 12:00:00 AM)
More..

Genta Inc. Mergers & Acquisitions
Genta Inc acquires Salus Therapeutics Inc (8/21/2003 12:00:00 AM)
Genta Inc intends a stock buyback (7/24/2002 12:00:00 AM)
Genta Inc acquires Androgenics Technologies Inc (9/8/1999 12:00:00 AM)
Promega Corp acquires JBL Scientific Inc(Genta Inc) from Genta Inc (3/22/1999 12:00:00 AM)
Genta Inc acquires Virna Pharmaceuticals (6/28/1991 12:00:00 AM)
Genta Inc acquires JBL Scientific Inc (2/27/1991 12:00:00 AM)
More..



  about us | contact us | public company index | private company index | pcan | widget | your privacy rights | terms & conditions  

Copyright © 2009 Alacra, Inc., 100 Broadway, Suite 1100, New York, NY 10005. All rights reserved.
Reproduction in whole or in part in any form or medium without express written permission is prohibited.